共 151 条
[21]
Mirlohi M(2012) with fructo-oligosaccharides in patients with non alcoholic steatohepatitis Dig Dis Sci. 57 545-49
[22]
Ghiasvand R(2011)Effects of J Pediatr Gastroenterol Nutr. 52 740-668
[23]
Khalesi S(2011) strain GG in pediatric obesity-related liver disease Eur Rev Med Pharmacol Sci. 15 1090-542
[24]
Johnson DW(2017)Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial J Dig Dis. 18 698-902
[25]
Campbell K(2018)Treatment efficacy of a probiotic preparation for nonalcoholic steatohepatitis: a pilot trial J Gastrointest Liver Dis. 27 41-1234
[26]
Lavekar AS(2017)A multi-strain probiotic reduces the fatty liver index, cytokines and aminotransferase levels in NAFLD patients: evidence from a randomized clinical trial Br J Nutr. 117 662-425
[27]
Raje DV(2014)Synbiotic supplementation in lean patients with nonalcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial Am J Clin Nutr. 99 535-2383
[28]
Manohar T(2015)Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study Future Microbiol. 10 889-13
[29]
Lavekar AA(2016)Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease Endocr Pract. 22 1224-106
[30]
Gao X(2016)Gut microbiota, prebiotics, probiotics, and synbiotics in management of obesity and prediabetes: review of randomized controlled trials Nat Rev Gastroenterol Hepatol. 13 412-537